<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e> (CCH) increases the risk of <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> (AD) through several biologically plausible pathways, but the relationship between CCH and the development of AD remains uncertain </plain></SENT>
<SENT sid="1" pm="."><plain>To investigate expression of APP, BACE1 and A beta in the hippocampus of BCCAO rats and study pathophysiological mechanism of AD from CCH </plain></SENT>
<SENT sid="2" pm="."><plain>CCH rat model was established by <z:hpo ids='HP_0011010'>chronic</z:hpo> bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> (BCCAO) </plain></SENT>
<SENT sid="3" pm="."><plain>Behavior was evaluated after BCCAO with <z:mp ids='MP_0001465'>Morris water maze</z:mp> and open-field task </plain></SENT>
<SENT sid="4" pm="."><plain>Expression of A beta was measured by enzyme linked immunosorbent assay (ELISA) </plain></SENT>
<SENT sid="5" pm="."><plain>beta-Amyloid precursor protein cleavage enzyme 1 (BACE1) and beta-amyloid precursor protein (APP) were tested by ELISA, Western blotting and RT-PCR </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0100543'>Cognitive impairment</z:hpo> occurred with CCH by <z:mp ids='MP_0001465'>Morris water maze</z:mp> test and open-field task </plain></SENT>
<SENT sid="7" pm="."><plain>The BACE1 and A beta level in BCCAO rats was more increased than sham-operation control rats (P &lt; 0.01) but APP had no difference(P &gt; 0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>The expression of BACE1 and A beta has no inter-group difference in BCCAO rats (P &gt; 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>The level of BACE1 and A beta had positive correlation with <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> (P &lt; 0.01) while no correlation was observed between APP and <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> contributes to <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> and vascular pathogenesis of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> that <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e> increases BACE1 and A beta level in brain </plain></SENT>
</text></document>